Healthtech startup Cent has raised $15 million in Series A funding in a round led by Blume Ventures, with existing investor South Park Commons also participating. The company will use the funding to improve its artificial intelligence (AI) technology, support medical research and development, and expand its clinical and engineering teams. The round includes both equity and debt, but the company has not disclosed the breakdown.

Founded in 2025, Cent focuses on preventive healthcare, helping people identify potential health problems before symptoms appear. Its platform combines medical imaging, AI-based analysis and biological data to help doctors detect diseases at an early stage. With the latest funding, the company plans to expand its services in India and improve access to preventive health screenings.

Key Highlights

• Cent Raises $15 Million to Expand AI-Powered Preventive Healthcare
• Cent Raises Series A Funding to Scale Preventive Health Screening Services

Funding to Support Technology and Research

The funding round also attracted several individual investors, including Arun Sarin, former chief executive of Vodafone, and Srinivas Narayanan, former business-to-business chief technology officer at OpenAI. Other investors included Sharath Narayana, Krishna Sridhar and Aprameya Radhakrishna.

Cent was founded by Shashank ND, who previously established healthcare platform Practo and OneFlow Holdings; Anshul Khandelwal, former chief marketing officer of Ola Electric; and Arpit Garg, former product head at Lenskart.

The company plans to invest in its AI systems, medical imaging technology and clinical research. It will also hire more people to support product development and day-to-day operations as it expands its services.

Cent aims to address a common problem in healthcare: many diseases are diagnosed only after symptoms appear. Through regular screenings and early disease detection, the company hopes to help people understand their health risks and seek medical attention sooner.

However, early screening results still need to be assessed by qualified doctors, and not every finding necessarily indicates a serious illness. The company will need to demonstrate that its approach delivers meaningful health benefits as it grows.

Whole-Body Screenings and Medsee Acquisition

Cent's main service, Cent Check, combines several diagnostic tests into a single visit lasting around two hours. The screening includes full-body magnetic resonance imaging (MRI), low-dose computed tomography (CT), bone density testing, electrocardiography (ECG), echocardiography and tests covering more than 100 biomarkers.

After the tests, doctors review the results and provide members with a personalised health plan. The company also offers ongoing support to help people manage their health. It operates in Bengaluru, Mumbai and Delhi and says it has completed 10,000 preventive whole-body scans since its launch.

According to the company's data, one in four members who considered themselves healthy before screening had a finding that required medical attention. One in 40 needed immediate attention. Reported findings included early-stage tumours, narrowed arteries and aneurysms. These figures are based on Cent's own screening results and have not been independently verified.

Cent has also acquired Medsee, an AI-powered radiology reporting platform founded by Chitra Singh. The technology helps radiologists prepare structured reports and identify findings that may need closer examination.

The acquisition is expected to help Cent handle a growing number of scans and improve the speed of report preparation. Medical professionals will continue to review the findings and make clinical decisions.

The company is also building a database from its screening programmes to better understand health patterns among people who do not show obvious symptoms. It plans to use this information to develop AI models that could help identify potential health risks and support medical research.

Cent aims to conduct 10 million scans by 2035. Reaching that target will require further investment in technology, medical expertise and operations.

Also Read: AI Startup Simplismart Raises $14 Million Funding in Series B Round

The latest funding gives the startup more resources to pursue its expansion plans. Its next challenge will be to make health screening services more accessible while ensuring that its technology supports reliable diagnoses and appropriate medical care.